Welcome to LookChem.com Sign In|Join Free

CAS

  • or

163457-22-5

Post Buying Request

163457-22-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

163457-22-5 Usage

Chemical Family

Belongs to the pyrrolidine family

Versatility

Acts as a versatile building block in organic synthesis

Industry Applications

Widely used in pharmaceutical and agrochemical industries

Reactivity

Known for its unique reactivity

Intermediate Role

Commonly used as a key intermediate in the synthesis of various biologically active compounds

Substituents

Contains 3,3-difluoro substituents

Medicinal Chemistry

Valuable tool in medicinal chemistry

Enhancement

Enhances the biological activity and pharmacokinetic properties of the final compounds

Field Importance

Important compound in drug discovery and development

Check Digit Verification of cas no

The CAS Registry Mumber 163457-22-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,4,5 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 163457-22:
(8*1)+(7*6)+(6*3)+(5*4)+(4*5)+(3*7)+(2*2)+(1*2)=135
135 % 10 = 5
So 163457-22-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H13F2NO2/c13-12(14)6-7-15(9-12)11(16)17-8-10-4-2-1-3-5-10/h1-5H,6-9H2

163457-22-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl 3,3-difluoropyrrolidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names benzyl 3,3-difluoro-1-pyrrolidine carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:163457-22-5 SDS

163457-22-5Downstream Products

163457-22-5Relevant articles and documents

Aminodifluorosulfinium salts: Selective fluorination reagents with enhanced thermal stability and ease of handling

Lheureux, Alexandre,Beaulieu, Francis,Bennett, Christopher,Bill, David R.,Clayton, Simon,Laflamme, Franois,Mirmehrabi, Mahmoud,Tadayon, Sam,Tovell, David,Couturier, Michel

experimental part, p. 3401 - 3411 (2010/07/07)

Diethylaminodifluorosulfinium tetrafluoroborate (XtalFluor-E) and morpholinodifluorosulfinium tetrafluoroborate (XtalFluor-M) are crystalline fluorinating agents that are more easily handled and significantly more stable than Deoxo-Fluor, DAST, and their analogues. These reagents can be prepared in a safer and more cost-efficient manner by avoiding the laborious and hazardous distillation of dialkylaminosulfur trifluorides. Unlike DAST, Deoxo-Fluor, and Fluolead, XtalFluor reagents do not generate highly corrosive free-HF and therefore can be used in standard borosilicate vessels. When used in conjunction with promoters such as Et3N3HF, Et3N2HF, or DBU, XtalFluor reagents effectively convert alcohols to alkyl fluorides and carbonyls to gem-difluorides. These reagents are typically more selective than DAST and Deoxo-Fluor and exhibit superior performance by providing significantly less elimination side products.

HETEROCYCLIC CETP INHIBITORS

-

Page/Page column 126, (2010/11/27)

Compounds of formula Ia and Ib wherein A, B, C and R1 are described herein.

1,2,4-OXADIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

-

, (2010/02/14)

The present invention is directed to novel 1,2,4-oxadiazole derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 163457-22-5